Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation
Nature – A mutant-selective AKT inhibitor shows potential as a targeted therapy for breast cancer, enabling enhanced target engagement and avoiding the dose-limiting toxicity associated with…